← Projects
P / 05Alpha Shaper · AlbioBiotech

Carbohydrate-absorption chewable tablets.

Commercial · Live · 100% Australian owned

A 100% Australian-owned chewable tablet line developed under the Albio brand. Pure plant extracts inhibit carbohydrate absorption to support a sugar-controlled metabolic pathway — positioned as a clinically considered alternative to dieting, stimulant fat-burners and surgical interventions across the weight-management category.

Key activities

  • Plant-extract carbohydrate-absorption inhibitor formulation.
  • Chewable tablet manufacturing to GMP / Australian-made standards.
  • Brand and channel development under the Albio brand.

Outcomes & targets

  • Commercial, live, 100% Australian-owned product line.
  • GMP · H&L · Australian Made credentials.
  • Metabolic / sugar-control positioning in weight management.

Industry context

Weight management is a crowded category dominated by dieting, stimulants and, increasingly, pharmaceutical and surgical interventions. A naturally derived, clinically considered carbohydrate-absorption approach offers a differentiated, lower-risk option.

Partners

Commercial · Live100% Australian OwnedGMP · H&L · Australian Made